A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer
Clinical trial NCT02013050 · COMPLETED
Trial details
- NCT number
- NCT02013050
- Sponsor
- Soligenix
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-12-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.